AbCellera Biologics annual total assets
2020
2021
2022
2023
2024
2025
AbCellera Biologics Total Assets Growth & History (ABCL)
AbCellera Biologics's total assets was $1.36B for fiscal 2025.
View full AbCellera Biologics company overviewAbCellera Biologics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.36B | −$3.6M | −0.26% |
| 2024 | 2024-12-31 | $1.36B | −$127.5M | −8.57% |
| 2023 | 2023-12-31 | $1.49B | −$52.8M | −3.43% |
| 2022 | 2022-12-31 | $1.54B | $222.3M | +16.86% |
| 2021 | 2021-12-31 | $1.32B | $313.0M | +31.13% |
| 2020 | 2020-12-31 | $1.01B | — | — |
AbCellera Biologics quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.31B | −$94.5M | −6.74% |
| Q1 2026 | 2026-03-31 | $1.31B | −$37.1M | −2.76% |
| Q4 2025 | 2025-12-31 | $1.36B | −$3.6M | −0.26% |
| Q3 2025 | 2025-09-30 | $1.36B | −$36.8M | −2.64% |
| Q2 2025 | 2025-06-30 | $1.40B | −$10.4M | −0.74% |
| Q1 2025 | 2025-03-31 | $1.34B | −$118.9M | −8.13% |
| Q4 2024 | 2024-12-31 | $1.36B | −$127.5M | −8.57% |
| Q3 2024 | 2024-09-30 | $1.39B | −$119.4M | −7.89% |
| Q2 2024 | 2024-06-30 | $1.41B | −$124.7M | −8.11% |
| Q1 2024 | 2024-03-31 | $1.46B | −$34.8M | −2.32% |
| Q4 2023 | 2023-12-31 | $1.49B | −$52.8M | −3.43% |
| Q3 2023 | 2023-09-30 | $1.51B | −$40.2M | −2.59% |
| Q2 2023 | 2023-06-30 | $1.54B | −$56.6M | −3.55% |
| Q1 2023 | 2023-03-31 | $1.50B | −$94.4M | −5.93% |
| Q4 2022 | 2022-12-31 | $1.54B | $222.3M | +16.86% |
| Q3 2022 | 2022-09-30 | $1.55B | $379.7M | +32.38% |
| Q2 2022 | 2022-06-30 | $1.59B | $441.9M | +38.37% |
| Q1 2022 | 2022-03-31 | $1.59B | $463.8M | +41.09% |
| Q4 2021 | 2021-12-31 | $1.32B | $313.0M | +31.13% |
| Q3 2021 | 2021-09-30 | $1.17B | — | — |
| Q2 2021 | 2021-06-30 | $1.15B | — | — |
| Q1 2021 | 2021-03-31 | $1.13B | — | — |
| Q4 2020 | 2020-12-31 | $1.01B | — | — |
AbCellera Biologics total assets trends
Over the last five fiscal years, AbCellera Biologics's total assets increased from $1.01B to $1.36B, a change of $351.4M. The latest reported quarter, Q2 2026, shows $1.31B.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AbCellera Biologics source filings ↗